Annual Working Capital
-$5.49 B
-$1.79 B-48.32%
31 December 2023
Summary:
AstraZeneca annual working capital is currently -$5.49 billion, with the most recent change of -$1.79 billion (-48.32%) on 31 December 2023. During the last 3 years, it has fallen by -$4.72 billion (-619.27%). AZN annual working capital is now -165.77% below its all-time high of $8.34 billion, reached on 31 December 2010.AZN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
-$1.77 B
+$1.40 B+44.19%
30 September 2024
Summary:
AstraZeneca quarterly working capital is currently -$1.77 billion, with the most recent change of +$1.40 billion (+44.19%) on 30 September 2024. Over the past year, it has increased by +$4.32 billion (+70.91%). AZN quarterly working capital is now -120.00% below its all-time high of $8.85 billion, reached on 30 June 2011.AZN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.3% | +70.9% |
| 3 y3 years | -619.3% | -158.2% |
| 5 y5 years | -682.9% | -41.0% |
AZN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -250.4% | at low | -148.5% | +70.9% |
| 5 y | 5 years | -250.4% | at low | -135.1% | +70.9% |
| alltime | all time | -165.8% | at low | -120.0% | +80.0% |
AstraZeneca Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.77 B(-44.2%) |
| June 2024 | - | -$3.17 B(-4.1%) |
| Mar 2024 | - | -$3.31 B(-39.7%) |
| Dec 2023 | -$5.49 B(+48.3%) | -$5.49 B(-9.8%) |
| Sept 2023 | - | -$6.09 B(+72.1%) |
| June 2023 | - | -$3.54 B(+36.3%) |
| Mar 2023 | - | -$2.59 B(-29.9%) |
| Dec 2022 | -$3.70 B(-201.4%) | -$3.70 B(-20.0%) |
| Sept 2022 | - | -$4.63 B(+415.1%) |
| June 2022 | - | -$898.00 M(+865.6%) |
| Mar 2022 | - | -$93.00 M(-102.5%) |
| Dec 2021 | $3.65 B(-578.4%) | $3.65 B(+20.0%) |
| Sept 2021 | - | $3.04 B(-39.8%) |
| June 2021 | - | $5.05 B(-281.9%) |
| Mar 2021 | - | -$2.78 B(+264.1%) |
| Dec 2020 | -$763.00 M(-70.1%) | -$763.00 M(-1.7%) |
| Sept 2020 | - | -$776.00 M(-76.1%) |
| June 2020 | - | -$3.25 B(-22.9%) |
| Mar 2020 | - | -$4.22 B(+65.3%) |
| Dec 2019 | -$2.55 B(+264.3%) | -$2.55 B(+103.3%) |
| Sept 2019 | - | -$1.26 B(+54.1%) |
| June 2019 | - | -$815.00 M(-82.3%) |
| Mar 2019 | - | -$4.61 B(+557.2%) |
| Dec 2018 | -$701.00 M(-78.3%) | -$701.00 M(-67.2%) |
| Sept 2018 | - | -$2.14 B(-55.0%) |
| June 2018 | - | -$4.75 B(-4.6%) |
| Mar 2018 | - | -$4.98 B(+54.1%) |
| Dec 2017 | -$3.23 B(+62.1%) | -$3.23 B(+290.0%) |
| Sept 2017 | - | -$829.00 M(-39.0%) |
| June 2017 | - | -$1.36 B(-64.2%) |
| Mar 2017 | - | -$3.79 B(+90.2%) |
| Dec 2016 | -$1.99 B(-275.2%) | -$1.99 B(-20.7%) |
| Sept 2016 | - | -$2.52 B(+147.9%) |
| June 2016 | - | -$1.01 B(-67.9%) |
| Mar 2016 | - | -$3.16 B(-377.9%) |
| Dec 2015 | $1.14 B(-279.8%) | $1.14 B(-140.1%) |
| Sept 2015 | - | -$2.84 B(+21.3%) |
| June 2015 | - | -$2.34 B(-23.8%) |
| Mar 2015 | - | -$3.07 B(+384.5%) |
| Dec 2014 | -$633.00 M(-114.8%) | -$633.00 M(-15.8%) |
| Sept 2014 | - | -$752.00 M(+537.3%) |
| June 2014 | - | -$118.00 M(-87.8%) |
| Mar 2014 | - | -$971.00 M(-122.7%) |
| Dec 2013 | $4.28 B(-16.7%) | $4.28 B(+4.1%) |
| Sept 2013 | - | $4.12 B(-1.9%) |
| June 2013 | - | $4.20 B(-6.4%) |
| Mar 2013 | - | $4.48 B(-12.9%) |
| Dec 2012 | $5.14 B(-33.6%) | $5.14 B(+31.9%) |
| Sept 2012 | - | $3.90 B(-21.6%) |
| June 2012 | - | $4.98 B(-13.6%) |
| Mar 2012 | - | $5.76 B(-25.7%) |
| Dec 2011 | $7.75 B(-7.1%) | $7.75 B(-0.7%) |
| Sept 2011 | - | $7.81 B(-11.8%) |
| June 2011 | - | $8.85 B(+18.8%) |
| Mar 2011 | - | $7.45 B(-10.7%) |
| Dec 2010 | $8.34 B | $8.34 B(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $7.72 B(+9.1%) |
| June 2010 | - | $7.07 B(+32.1%) |
| Mar 2010 | - | $5.35 B(-12.5%) |
| Dec 2009 | $6.12 B(+149.4%) | $6.12 B(+12.8%) |
| Sept 2009 | - | $5.42 B(+36.2%) |
| June 2009 | - | $3.98 B(+120.9%) |
| Mar 2009 | - | $1.80 B(-26.5%) |
| Dec 2008 | $2.45 B(+29.5%) | $2.45 B(+120.3%) |
| Sept 2008 | - | $1.11 B(+129.7%) |
| June 2008 | - | $485.00 M(-139.4%) |
| Mar 2008 | - | -$1.23 B(-164.9%) |
| Dec 2007 | $1.90 B(-74.7%) | $1.90 B(-326.4%) |
| Sept 2007 | - | -$837.00 M(-90.5%) |
| June 2007 | - | -$8.86 B(-249.1%) |
| Mar 2007 | - | $5.94 B(-20.7%) |
| Dec 2006 | $7.49 B(+8.1%) | $7.49 B(+18.0%) |
| Sept 2006 | - | $6.34 B(-4.5%) |
| June 2006 | - | $6.65 B(-11.3%) |
| Mar 2006 | - | $7.49 B(+8.1%) |
| Dec 2005 | $6.93 B(+7.7%) | $6.93 B(+9.1%) |
| Sept 2005 | - | $6.35 B(-4.3%) |
| June 2005 | - | $6.64 B(-4.2%) |
| Mar 2005 | - | $6.93 B(+7.7%) |
| Dec 2004 | $6.44 B(+22.9%) | $6.44 B(+17.2%) |
| Sept 2004 | - | $5.49 B(+10.9%) |
| June 2004 | - | $4.95 B(-10.2%) |
| Mar 2004 | - | $5.51 B(+5.3%) |
| Dec 2003 | $5.24 B(+33.9%) | $5.24 B(-11.2%) |
| Sept 2003 | - | $5.90 B(+14.7%) |
| June 2003 | - | $5.14 B(+7.4%) |
| Mar 2003 | - | $4.79 B(+22.5%) |
| Dec 2002 | $3.91 B(+0.7%) | $3.91 B(-15.5%) |
| Sept 2002 | - | $4.63 B(+8.8%) |
| June 2002 | - | $4.26 B(-6.3%) |
| Mar 2002 | - | $4.54 B(+16.9%) |
| Dec 2001 | $3.88 B(+7.3%) | $3.88 B(-18.3%) |
| Sept 2001 | - | $4.76 B(+6.1%) |
| June 2001 | - | $4.48 B(+0.1%) |
| Mar 2001 | - | $4.48 B(+23.6%) |
| Dec 2000 | $3.62 B(+25.1%) | $3.62 B(-7.7%) |
| Sept 2000 | - | $3.92 B(+13.6%) |
| June 2000 | - | $3.45 B(-4.4%) |
| Mar 2000 | - | $3.61 B(+24.8%) |
| Dec 1999 | $2.90 B(-22.9%) | $2.90 B(-31.2%) |
| Sept 1999 | - | $4.21 B(+10.6%) |
| June 1999 | - | $3.81 B(+1.4%) |
| Dec 1998 | $3.75 B(+128.7%) | $3.75 B(+152.6%) |
| June 1998 | - | $1.49 B(-9.5%) |
| Dec 1997 | $1.64 B(-17.7%) | $1.64 B(-17.7%) |
| Dec 1996 | $2.00 B(+14.9%) | $2.00 B(+14.9%) |
| Dec 1995 | $1.74 B(+9.7%) | $1.74 B(-1.2%) |
| June 1995 | - | $1.76 B(+10.9%) |
| Dec 1994 | $1.58 B(+12.8%) | $1.58 B(+12.8%) |
| Dec 1993 | $1.40 B(-817.5%) | $1.40 B |
| Dec 1992 | -$195.65 M(-109.6%) | - |
| Dec 1991 | $2.04 B(+5.6%) | - |
| Dec 1990 | $1.93 B | - |
FAQ
- What is AstraZeneca annual working capital?
- What is the all time high annual working capital for AstraZeneca?
- What is AstraZeneca annual working capital year-on-year change?
- What is AstraZeneca quarterly working capital?
- What is the all time high quarterly working capital for AstraZeneca?
- What is AstraZeneca quarterly working capital year-on-year change?
What is AstraZeneca annual working capital?
The current annual working capital of AZN is -$5.49 B
What is the all time high annual working capital for AstraZeneca?
AstraZeneca all-time high annual working capital is $8.34 B
What is AstraZeneca annual working capital year-on-year change?
Over the past year, AZN annual working capital has changed by -$1.79 B (-48.32%)
What is AstraZeneca quarterly working capital?
The current quarterly working capital of AZN is -$1.77 B
What is the all time high quarterly working capital for AstraZeneca?
AstraZeneca all-time high quarterly working capital is $8.85 B
What is AstraZeneca quarterly working capital year-on-year change?
Over the past year, AZN quarterly working capital has changed by +$4.32 B (+70.91%)